Sarpogrelate-Aspirin Comparative Clinical Study for Efficacy and Safety in Secondary Prevention of Cerebral Infarction (S-ACCESS)
Clinical trial NCT00129805 · COMPLETED
Trial details
- NCT number
- NCT00129805
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2001-01-01
- Primary completion
- 2004-09-01
- Enrollment
- 1510
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.